Technical Factors behind Discordant Results with Liquid Biopsies

Technical factors are a major source of variation in liquid biopsy test results, according to a study published online March 14 in the Journal of Clinical Oncology. While biological factors, … [Read more...]


New Lab-Based, ER Protocol Cuts Invasive Procedures in Febrile Infants

A prediction rule can identify febrile infants at low risk for serious blood infections (SBIs) using urinalysis, absolute neutrophil count (ANC), and procalcitonin levels, according to a study … [Read more...]


Diagnostics Sector Saw Increased Investment, Exits in 2018

Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment, according to Silicon Valley Bank's Trends in Healthcare Investments and … [Read more...]


Big Data Can Reshape Lab Reference Values in the Era of Personalized Medicine

As might be expected, there are substantial differences in "normal" laboratory values determined by healthy outpatients and critically ill patients in the intensive care unit (ICU). However, even … [Read more...]


AI May Cut ‘Wrong Blood in Tube’ Errors

Machine learning-based multianalyte delta checks may be effective at identifying 'wrong blood in tube' (WBIT) errors, according to a proof-of-concept study published in the American Journal of … [Read more...]


Laboratory Information Systems (LIS): What You Need To Know To Get Paid

By Sean McSweeney  bio Today, laboratory billing claims require more and more data to successfully get paid. One of the biggest reasons your claims may be getting denied is because you're … [Read more...]


Methods for Reanalysis of Exome Sequencing Emerging

Clinical whole-exome sequencing (WES) offers diagnosis for approximately 30 percent of patients, but it has exponentially increased the number of variants identified—many of which are of unknown … [Read more...]


Next-Gen Sequencing, AI Driving Investor Interest in Diagnostics Sector

There is "intense" investor interest and "substantial" investment occurring in the next generation of diagnostics and tools companies (Dx/Tools), according to a year-end report … [Read more...]


Innovation: AMP Issues New Guidelines for NGS Pipeline Validation

Molecular next-generation sequencing (NGS) tests have spurred tremendous growth in the lab industry. But as often happens with innovation, NGS technology may be moving faster than development of … [Read more...]


Unlocking Value in Laboratory Data

A recurring theme at G2's 35th annual Lab Institute conference (Washington D.C.; Oct. 25-27) was the central role laboratory data can play in the health care system's shift to value-based care. This … [Read more...]